Biolase, Inc. BIOLQ
0.00
0.00
NaN
as of 23 Sep
- Market cap
- $2.3M
- P/E
- 0.0×
Follow BIOLQ
Growth Flags
show if company had growth for consecutive years
| Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.03 | 0.10 | 1.47 | 1.12 | 0.34 | 0.44 | 0.66 | 1.63 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(0.62) | (0.88) | (18.53) | (18.93) | (2.75) | (5.71) | (7.28) | (26.89) |
P/B ratio |
0.00 | 1.00 | 2.29 | 2.58 | 34.09 | 1.83 | 1.06 | 3.83 |
Price to Tangible BV |
0.00 | 2.50 | 2.59 | 3.65 | 0.00 | 2.49 | 1.18 | 4.42 |
EV/Sales |
0.18 | 0.30 | 1.06 | 1.06 | 0.53 | 0.57 | 0.48 | 1.52 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(0.63) | (0.54) | (2.47) | (1.89) | (1.59) | (1.84) | (1.22) | (7.43) |
EV/FCF |
(0.58) | (0.48) | (2.37) | (1.87) | (1.56) | (1.78) | (1.17) | (6.55) |
Quick Ratio |
0.61 | 0.56 | 2.49 | 1.87 | 0.58 | 1.22 | 1.65 | 1.05 |
Current Ratio |
1.26 | 1.63 | 3.57 | 3.13 | 1.05 | 2.09 | 2.70 | 1.89 |
Net Debt/EBITDA |
(0.51) | (0.41) | 1.04 | 0.08 | (0.51) | (0.13) | 0.71 | 0.65 |
Debt/Assets |
40.02% | 36.12% | 25.34% | 40.20% | 42.29% | 28.13% | 0.00% | 0.38% |
Debt/Equity |
7.18 | 2.82 | 0.56 | 1.64 | 3.10 | 0.98 | 0.00 | 0.01 |
Asset Turnover |
1.34 | 1.04 | 0.81 | 0.63 | 1.07 | 1.13 | 1.11 | 1.23 |
Operating CF/Net income |
0.37 | 0.93 | 1.00 | 0.37 | 0.71 | 0.66 | 0.88 | 0.60 |
Capex/Depreciation |
(0.35) | (2.20) | (0.77) | (0.10) | (0.16) | (0.41) | (0.62) | (1.35) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (1,620.81%) | (191.94%) | (95.22%) | (665.05%) | (311.44%) | (106.65%) | (81.17%) | (74.72%) | |
| (102.66%) | (61.73%) | (34.69%) | (93.88%) | (50.75%) | (52.80%) | (49.05%) | (41.70%) | |
ROIC |
(118.79%) | (109.22%) | (113.59%) | (134.04%) | (83.37%) | (96.20%) | (64.93%) | (71.66%) |
Return on Tangible Assets |
(350.76%) | (186.98%) | (45.67%) | (138.66%) | (733.87%) | (111.40%) | (79.04%) | (85.84%) |
Average Days of Receivables |
40.71 | 43.99 | 39.47 | 49.01 | 84.59 | 87.88 | 78.75 | 68.93 |
Research and Development Expense of Revenue |
12.21% | 14.99% | 15.43% | 16.22% | 12.61% | 11.27% | 13.27% | 15.05% |
Selling, General and Administrative Expense of Revenue |
58.29% | 70.13% | 67.87% | 92.25% | 66.52% | 64.76% | 56.32% | 53.02% |
Intangible Assets out of Total Assets |
0.08 | 0.08 | 0.05 | 0.07 | 0.09 | 0.08 | 0.07 | 0.07 |
Share Based Compensation of Revenue |
3.42% | 4.75% | 4.24% | 22.00% | 7.38% | 6.00% | 4.70% | 5.92% |
Graham Net Nets |
(5.89) | (0.89) | 0.34 | 0.16 | (0.04) | 0.29 | 0.72 | 0.17 |
Graham Number |
11.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(2,961.82%) | (577.38%) | (29.40%) | (141.59%) | (142.93%) | (106.06%) | (55.54%) | (18.39%) |
Free Cash Flow Yield |
(1,082.66%) | (622.24%) | (30.28%) | (50.51%) | (100.80%) | (72.28%) | (61.85%) | (14.21%) |
Revenue per Share |
38.47 | 702.35 | 664.20 | 929.80 | 4,064.41 | 5,628.66 | 7,953.56 | 10,573.47 |
Operating CF per Share |
(11.03) | (387.84) | (283.22) | (522.24) | (1,370.54) | (1,725.24) | (3,120.68) | (2,162.45) |
Capex per Share |
(0.88) | (54.01) | (11.98) | (3.92) | (22.26) | (63.66) | (126.61) | (288.57) |
Free Cash Flow per Share |
(11.91) | (441.86) | (295.20) | (526.16) | (1,392.80) | (1,788.90) | (3,247.29) | (2,451.02) |
Cash per Share |
5.14 | 60.59 | 511.44 | 729.63 | 656.02 | 1,019.02 | 2,016.27 | 1,872.45 |
Shareholders Equity per Share |
1.53 | 70.86 | 427.25 | 409.31 | 466.88 | 1,352.32 | 4,959.32 | 4,503.06 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.53 | 70.86 | 427.25 | 409.31 | 466.88 | 1,352.32 | 4,959.32 | 4,503.06 |
Free Cash Flow |
(15.22) | (30.49) | (17.42) | (12.89) | (12.95) | (14.67) | (19.16) | (12.01) |
Working Capital |
5.20 | 11.15 | 35.51 | 23.89 | 1.24 | 17.34 | 22.68 | 15.97 |
Capital Expenditures |
(1.13) | (3.73) | (0.71) | (0.10) | (0.21) | (0.52) | (0.75) | (1.41) |
Net Current Asset Value |
(8.28) | (4.34) | 19.28 | 4.11 | (0.49) | 5.88 | 22.33 | 14.11 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.08 | 0.02 | 0.00 | 0.01 | 0.01 | 0.02 | 0.03 |
Net Profit Margin |
(76.52%) | (59.53%) | (42.63%) | (150.16%) | (47.24%) | (46.62%) | (44.39%) | (33.88%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.58 | 0.40 | 0.86 | 1.27 | 1.10 | 0.64 | 0.33 | 0.23 |
Cash ROIC |
(86.92%) | (135.77%) | (25.62%) | (30.58%) | (58.29%) | (53.24%) | (53.66%) | (48.01%) |
Accounts Receivable Turnover |
8.68 | 9.62 | 10.74 | 3.85 | 3.80 | 4.35 | 4.71 | 5.53 |
Accounts Payable Turnover |
5.47 | 7.16 | 7.60 | 4.16 | 4.17 | 5.29 | 4.47 | 4.18 |
Inventory Turnover |
2.38 | 2.26 | 1.88 | 1.50 | 2.02 | 2.38 | 2.46 | 2.42 |
Average Days of Payables |
68.24 | 64.88 | 53.30 | 58.27 | 82.78 | 74.26 | 58.64 | 105.73 |
Days of Inventory on Hand |
128.64 | 178.11 | 208.27 | 245.22 | 170.69 | 152.79 | 141.16 | 156.69 |
Average Receivables |
5.66 | 5.04 | 3.65 | 5.91 | 9.94 | 10.62 | 9.95 | 9.37 |
Average Payables |
5.93 | 4.55 | 2.98 | 3.99 | 5.64 | 5.53 | 7.12 | 7.54 |
Average Inventory |
13.66 | 14.41 | 12.04 | 11.08 | 11.62 | 12.27 | 12.91 | 13.04 |
Average Assets |
36.64 | 46.74 | 48.15 | 36.44 | 35.18 | 40.75 | 42.46 | 42.10 |
Average Common Equity |
2.32 | 15.03 | 17.54 | 5.14 | 5.73 | 20.17 | 25.66 | 23.50 |
Columns are period end dates